Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. …
Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $0 worth of Bausch + Lomb Corporation stock.
On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $1.35B worth of stock each year.
Highest buying activity among insiders over the last 12 months: SAUNDERS BRENT L (CEO and Chairman of the Board) — $2.02M.
The last purchase of 32,250 shares for transaction amount of $505,067 was made by SAUNDERS BRENT L (CEO and Chairman of the Board) on 2024‑08‑05.
2024-08-05 | CEO and Chairman of the Board | 32,250 0.0093% | $15.66 | $505,067 | +24.22% | |||
2022-06-01 | Sale | 9.1M 2.724% | $17.05 | $155.21M | -1.47% | |||
2022-05-10 | Sale | 70M 19.4359% | $17.05 | $1.19B | -8.60% |
Fil Ltd | $141.6M | 2.33 | 8.19M | +0.86% | +$1.21M | 0.14 | |
GoldenTree Asset Management | $81.58M | 1.34 | 4.72M | 0% | +$0 | 7.14 | |
Maple Rock Capital Partners Inc | $64.79M | 1.06 | 3.75M | 0% | +$0 | 4.1 | |
ICAHN CARL C | $60.55M | 1 | 3.5M | 0% | +$0 | 0.54 | |
River Road Asset Management | $32.66M | 0.54 | 1.89M | -2.59% | -$867,456.59 | 0.44 |